Recombinant DYRK1B (2.5 ng per reaction; catalog no. D09-10BG-10; SignalChem, Richmond, BC, Canada) phosphorylation of DyrkTide (40 µM;, RRRFRPASPLRGPPK; catalog no. D96-58; SignalChem) was measured in a reaction buffer containing 10 mM MgCl2, 20 mM Tris pH 7.5, and 10 μM adenosine triphosphate. Drug candidates (CC-401 and STF-785) were assayed at fourfold dilutions starting at 20 μM; final 2% dimethyl sulfoxide (DMSO). Reactions were terminated after 90 minutes at 30°C and kinase activity was measured using ADP-Glo Kinase Assay (V6930; Promega, Madison, WI). An analogous experiment was conducted with p27 (25 ng per reaction; catalog no. 56279; Abcam) as the reaction substrate instead of DyrkTide, with other reaction components unchanged. Reactions were conducted in the presence and absence of 1 μM CC-401 or 1% DMSO. Control reactions lacking DYRK1A (2.5 ng per reaction, SignalChem D09-10G-10) or adenosine triphosphate were also conducted. After 60 minutes at 30°C, reactions were quenched and run on sodium dodecyl sulfate–polyacrylamide gel electrophoresis under reducing conditions. Total p27 and phospho-p27 were quantified by western blot. Kinome screening and kinase inhibition assays were performed by DiscoveRx (San Diego, CA) (18).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.